In Brief
Microtubule-inhibiting small molecules are crucial for cell biology research and in cancer therapy. Photostatins are microtubule inhibitors that can be switched on and off in vivo by visible light, modulating microtubule dynamics with subsecond response time, and controlling mitosis with single-cell spatial precision. Photostatins are also 250 times more cytotoxic under blue light than when kept in the dark, making them both valuable tools for cell biology, and promising as precision-targeted chemotherapeutics.
INTRODUCTION
Microtubules (MTs) are highly dynamic components of the cytoskeleton that play vital roles in a variety of cellular processes, including intracellular transport, cell motility, and proliferation (Dumontet and Jordan, 2010) . As such, small molecule inhibitors that interfere with MT dynamics are indispensible tools in cell biology (Peterson and Mitchison, 2002) . In medicine, they are one of the most clinically useful classes of chemotherapeutics, due to their antimitotic and pro-apoptotic effects (Jordan et al., 1998) . However, the current inhibitors are nonspecific in the sense that their bioactivity cannot be either spatially or temporally directed, e.g., against selected cells and tissues, at defined times. This restricts their scope of application in research, as it prevents their use in spatially or temporally addressing the varied processes dependent on microtubule dynamics. In cancer medicine, this nonspecificity causes severe systemic side effects such as cardiotoxicity and neurotoxicity (Ghinet et al., 2013; Hooper et al., 2013; Tozer et al., 2002; Tron et al., 2006) , which limit the doses at which chemotherapeutics can be applied, thus impairing their therapeutic value (Dumontet and Jordan, 2010; Gill et al., 2014; Stanton et al., 2011) . Therefore, developing inhibitors of MT dynamics whose action can be targeted to specific cells at defined times is an important challenge (Velema et al., 2014) .
Optically controlling MT inhibitors could be an elegant solution to this problem of specificity, since light can be applied with high spatiotemporal precision (Velema et al., 2014) . Small molecule approaches are particularly attractive, since genetic engineering is not required and dosing is straightforward, so their scope for practical applications to both research and medicine is extensive. Prior research toward the optical modulation of MT inhibitors has explored both photobleachable and photouncageable drugs (Hadfield et al., 2002; Hamaguchi and Hiramoto, 1986; Velema et al., 2014; Wü hr et al., 2010) , and a photoactivation approach based on carbon-carbon double bond isomerization has been proposed (Bisby et al., 2013; Hadfield et al., 2002) . However, the nonspecific toxicity of these designs may be significant, since short wavelengths and/or high light intensity are required, leading to side reactions and toxic byproducts (Wu et al., 2009) . Fundamentally though, such irreversibly triggered approaches cannot combat the diffusion of the active drug, so they will always suffer from limited spatiotemporal resolution. Spatially and temporally restricting bioactivity instead demands reversible, in situ switching over many off4on cycles (Velema et al., 2014) . We here present a series of MT inhibitors that can be fully reversibly photoswitched by low-intensity visible light, to control microtubule structure, dynamics, and a range of MTdependent processes in living cells and organisms, with the spatiotemporal precision of light.
RESULTS

Design and Photoswitching of Photostatins
We designed the photostatins (PSTs) as reversibly photoswitchable analogs of combretastatin A-4 (CA4) (Pettit et al., 1989) . CA4 is one of the most prominent colchicine domain MT inhibitors (CDIs). Its potency, its vascular disrupting and antiangiogenic properties, and its avoidance of multidrug-resistance make it a promising candidate for tumor chemotherapy, and three CA4 derivatives have progressed to clinical trials (Tozer et al., 2002; Tron et al., 2006) . The CA4 pharmacophore is a trimethoxybenzene ring held cis to a low-steric-demand, methoxy-bearing arene (Bhattacharyya et al., 2008) . Crucially, trans-CA4 is several orders of magnitude less potent than the cis isomer (Tron et al., 2006) . We replaced the bridging C=C double bond of the stilbenoid combretastatins with an isosteric N=N double bond to give the azobenzene PSTs, which can be trans4cis photoisomerized with full reversibility and excellent photostability over many cycles by low intensity visible light (Figure 1) . We anticipated that the cis-PSTs would reproduce the valuable pharmacology of CA4, while their trans isomers would be biologically inactive. We aimed to reversibly photoswitch PSTs between the cis and trans isomeric forms in situ, to turn their bioactivity on and off, with high spatiotemporal precision, inside living cells and organisms.
We synthesized a series of PSTs (PST-1-PST-5) by diazonium coupling, in two to four synthetic steps (Figure 1 and Supplemental Information) (Thorn-Seshold et al., 2014) . Considering the solubility problems that have hampered the combretastatins, we also prepared PST-1P and PST-2S, as azobenzene analogs (''azologues'') of two nonspecific combretastatin prodrugs that have entered Phase III clinical trials: PST-1P is an azologue of CA4 phosphate (known as CA4P or ''fosbretabulin'') and PST-2S is an azologue of the serinyl anilide ''ombrabulin'' (Ohsumi et al., 1998; Pettit and Rhodes, 2009 ). Lastly, PST-1CL was synthesized to explore dual optical-and-biochemical targeting via exopeptidases (Thorn-Seshold et al., 2012) .
The switching of the PSTs was demonstrated by UV-Vis spectroscopy ( Figure 1D and Supplemental Information, Part B). All compounds were rapidly and fully reversibly photoswitched in phosphate-buffered saline (PBS) buffer, without degradation over hundreds of cycles, by low-power illumination. Their para-methoxy substituents enable PSTs to be trans4cis photoswitched using visible light (Knoll, 2003) , benefiting in vivo compatibility: 380-420 nm light gives approximately 90% cis isomer, which bears the CDI pharmacophore; longer wavelengths give decreasing cis percentages until 500-530 nm gives approximately 85% trans isomer, which does not bear the pharmacophore (Figure S1A ). In the dark, spontaneous (unidirectional) cis/trans isomerization leads to 100% trans isomer, with half-lives t, ranging from 0.8-120 min ( Figure S1B ), being modulated by the substitution pattern (Knoll, 2003) . This process acts as a safety mechanism, whereby the concentration of bioactive cis isomer will drop to zero unless blue light pulses are reapplied on the timescale of this reversion half-life. Therefore, even without using green light to actively switch off the PSTs, any cis-PST diffusing into a non-illuminated area, or remaining after a period of illumination, will spontaneously and rapidly be isomerized to trans, thus spatiotemporally restricting the PSTs' inhibitory bioactivity to illuminated zones only.
The Toxicity of PSTs Depends on Illumination Conditions
The potency, robustness, and light-specificity of the PSTs' biological effects were directly assessed in cellulo. Trans-PSTs were assayed by shielding experiments from light (100% trans; ''dark regime''), while cis-PSTs were assayed by applying a ''toxic regime'' of frequently pulsed, short illuminations (e.g., 75 ms pulses of 390 nm light every 15 s). To apply these illuminations in cell culture, we hand-built a cheap, computerized LED lighting system to illuminate > 30 well plates separately with independent wavelengths and timings ( Figure S6 and Supplemental Information). Crystal violet assays in the MDA-MB-231 human breast cancer cell line showed that PSTs are powerfully cytotoxic under the toxic lighting regime, but not in the dark. Their EC 50 values of 0.5-5.4 mM under the toxic regime represent potencies up to 100 times greater than under the dark regime , and closely similar results were obtained for the PSTs' lightdependent cytotoxicity in HeLa (cervical cancer) cells ( Figures  S2J-S2N) .
We then investigated the dependency of the PSTs' bioactivity on the irradiating wavelength in detail. We examined the proliferation of HeLa cells exposed to PST-1P, after pulsed illuminations at a range of wavelengths from 370-535 nm, by MTT assay (Figures 2C and 2D) . Illumination at 380-390 nm gave the most potent cytotoxicity, while the dose-response curves for wavelengths up to 525 nm were translated progressively higher concentrations by factors that match the relative trans/cis ratios at those wavelengths ( Figure S1C ). This supports the conclusions that the choice of illuminating wavelength determines the concentration of the cis form generated, and that this cis concentration is the primary determinant of the PSTs' bioactivity. For comparison, the trans isomer (assayed under dark conditions) was confirmed to be > 250 times less toxic than the cis form, and also showed a markedly shallower dose-dependency that could argue for a different biochemical mechanism of toxicity ( Figure 2D , Figure S1C , and Supplemental Information, Part C1). These experiments indicate how the PSTs' biological effects can be not only sharply controlled (illuminated or dark), but also finely tuned (wavelength dependence) by lighting conditions.
PSTs Induce Mitotic Arrest and Cell Death in a Light-Dependent Manner
We pursued further studies of the mechanism and light-dependency of PST-induced cytotoxicity focusing on PST-1 and its prodrug PST-1P. We first assayed cell membrane permeability (propidium iodide exclusion assay) and nuclear fragmentation (quantification of DNA content) in MDA-MB-231 cells. Neither assay showed a response to PST-1 below 50 mM in the dark regime. However, under the toxic regime, even submicromolar PST-1 induced loss of membrane integrity, and depletion of nuclear DNA content resulting in the emergence of hypodiploid (sub-G 1 ) cells (Figures 3A and 3B and Figure S3E) . Similar results were obtained in Jurkat (T cell lymphoma) and HeLa cells ( Figures S3A-S3D ). We subsequently examined cleavage of poly(ADP-ribose) polymerase (PARP). Full-length PARP (116 kDa) is involved in the repair of DNA damage caused by a variety of cellular stresses. During apoptosis, PARP is cleaved by caspase-3, caspase-7, and possibly by other suicidal proteases, into an 89-kDa catalytic fragment and a 24-kDa DNAbinding domain (Chaitanya et al., 2010) . HeLa cells treated with PST-1P were analyzed by western blot and showed the PARP proteolytic signature typical of apoptosis only under the toxic lighting regime ( Figure 3C ). Finally, cell-cycle analysis of MDA-MB-231 cells treated with PST-1 showed G 2 /M phase arrest beginning sharply around 500 nM under the toxic regime ( Figures 3D and 3E ), matching the EC 50 values seen in the cytotoxicity assays. By contrast, in the dark even 100 mM of PST-1 had no effect on cell-cycle repartition (Figures S3F and S3G) . As G 2 /M arrest is typical of MT-disrupting agents (Tron et al., 2006) , this supports the design conjecture that only cis-PSTs inhibit MT dynamics. Similar results were obtained in HEK293T (human embryonic kidney) and HeLa cells (Figures S3I and S3J) . We also explored a dual wavelength ''rescue protocol,'' to illustrate repeated, dynamic photocontrol over PST cytotoxicity. In this protocol, each pulse contains a component at 390 nm immediately followed by another at 515 nm (so that the transiently formed cis is reisomerized back to trans during each pulse). The rescue substantially reduced G 2 /M arrest compared to the toxic regime ( Figure S3H ). This highlights that PSTs can be reversibly and efficiently photoisomerized in cellulo in the long term (>5,000 trans/cis/trans photoswitching cycles over 2 days), without degradation of the drug and without phototoxicity to the cell.
Taken together, these results support the interpretation that the cis-PSTs generated in situ upon blue light exposure potently induce mitotic arrest, presumably linked to the activation of the spindle assembly checkpoint, and result in cell death which displays many characteristics of apoptosis. By contrast, the trans-PSTs that are established under dark conditions (or which predominate under longer wavelength illumination) are all but inactive due to their 100-fold weaker cytotoxicity, which additionally does not involve mitotic arrest. Both these results are general across a range of cell lines, supporting the conjecture that PSTs should be appropriate for use in any eukaryotic system. These experiments thereby supported our overall design, showing that PSTs can be used as antimitotic cytotoxins that can be robustly and reversibly photoswitched in living cells between the essentially ''off'' trans form and the potent ''on'' cis form. We now turned our focus to testing the specific molecular premise of the PSTs' design: by evaluating their capacity to effect MT disruption in situ in a reversibly photoswitchable manner.
PSTs Bind Tubulin and Inhibit Its Polymerization in a Light-Controlled Manner
To validate tubulin as the molecular target of cis-PSTs, we first assayed the ability of PST-1 to bind to the colchicine domain on tubulin. We used purified tubulin in an in vitro radioligand scintillation proximity assay (SPA) (Tahir et al., 2000) to examine the competitive displacement of 3 H-colchicine from its tubulin binding site by PST-1 under light and dark conditions. This assay confirmed that cis-PST-1 competes dose dependently with colchicine for tubulin binding, as does its isosteric parent drug CA4 ( Figure 4A ). The SPA returned an EC 50 value of 30 mM for PST-1 under 390 nm illumination, with the reference compound CA4 showing higher affinity (EC 50 = 0.16 mM), which mirrors the activity difference shown previously in the cytotoxicity assays. Importantly, trans-PST-1 showed no significant competitive binding to tubulin, further supporting the off4on design conjecture of our study.
We next assayed PST-1 for inhibition of tubulin polymerization in a biochemical assay using purified tubulin. PST-1 strongly inhibited in vitro tubulin polymerization under 390 nm illumination in a dosedependent manner (EC 50 5 mM), but exerted no inhibitory effects in the dark (EC 50 >> 40 mM; Figure 4B ). Lastly, we confirmed PST-1's functional potency as photoswitchable MT inhibitor in live cells by immunofluorescence imaging of endogenous tubulin. In the dark, PST-1 had no effects on MT structure, but under the toxic regime PST-1 caused dose-dependent MT depolymerization, as well as nuclear fragmentation that is typical of apoptotic cells, as seen with the reference compound CA4 (Figure 4C, Figure S4A ). This indicates that cis-PST-1 is a powerful inhibitor of tubulin polymerization both in vitro and in cellulo, while trans-PST-1 is not.
PSTs Achieve Reversible Optical Control over Microtubule Dynamics in Live Cells
To directly visualize PSTs' effects on MT dynamics in live cells, we imaged the end-binding protein EB3. EB3 clusters at the plus tips of growing MTs, and dissociates in phases of MT shrinkage. As its binding/unbinding kinetics are fast, EB3 imaging thus reveals MT growth dynamics (Bieling et al., 2007; Maurer et al., 2012) . We treated interphase cells expressing mCherrytagged EB3 with PST-1, and imaged them while photoswitching PST-1 in situ with alternating 2 min phases of pulsed 405 nm and 514 nm illuminations. Control cells (without PST-1 treatment) showed no variation of comet behavior with the illumination phase. In contrast, under PST-1 treatment, applying 405 nm light led to the disappearance of EB3 comets in less than a second, while changing to a 514 nm phase restored comet size and dynamics-also in less than a second-and this switching was entirely reversible over many cycles (Movies S1 and S2; Figure 5A ; see also Supplemental Information). We used the MATLAB software u-track (Applegate et al., 2011) to identify, follow, and quantify the EB3 comets from several independent movies (Movie S3), conservatively analyzing for the total number of EB3 comets, as well as their lifetime, speed, and distance traveled. The combined statistics show that trans4cis photoisomerizations of PST-1 inside living cells achieve optical switching of these functional parameters of MT polymerization dynamics, thus allowing fully reversible switching between phases of ordinary MT dynamics and of MT catastrophe simply by applying light (Figures 5B-5E ). Together with the preceding results, these experiments indicate that PSTs are a robust and powerful tool for precise, rapid, reversible, and noninvasive optical control over both MT dynamics and MT-dependent processes, suitable for both short-and long-term use in a range of systems from in vitro to in cellulo.
PSTs Control Mitosis and the Microtubule Cytoskeleton In Vivo
We next examined PST-1's optical control over MT dynamics in vivo. We monitored mitotic progression of developing C. elegans embryo as a readout of functional microtubule dynamics. The synchronicity of several blastomeres at early developmental stages gives a useful internal control for the normal mitosis rate (Strome and Wood, 1983) . We used transgenic embryos with mCherry-tagged cell membrane marker PH and histone H2B to identify blastomeres and follow their cell-cycle progression. Embryos were bathed in PST-1, and individual cells within 8-to 32-cell stage embryos were targeted with millisecond pulses of 405 and/or 514 nm light, once the chromosomes organized into a single plate (entry to metaphase). Applying 405 nm pulses blocked the targeted cell in metaphase ( Figure 6A ; Movie S4), but cells targeted by a 405 + 514 nm rescue protocol divided normally ( Figure 6B ; Movie S5). Crucially, in both cases, neighboring cells continued mitosis unperturbed. Thus, PST-1 can achieve reversible, optical control over MT dynamics and its dependent processes in vivo, and can execute that control with single-cell spatial precision.
Lastly, we examined PSTs' control over the MT cytoskeleton in mammalian tissue in vivo. We selected the highly watersoluble prodrug PST-1P to avoid needing a cosolvent, aiming at better in vivo compatibility. The cremaster muscle tissue of living mice was superfused (Baez, 1973) for 40 min with PST-1P, while being either illuminated at 390 nm with a lowpower LED or else kept in the dark. Then, under red light conditions, animals were sacrificed and the tissue was excised, fixed, and stained for MTs. PST-1P destroyed the MT network under 390 nm illumination, but caused no disruptive effects in the dark ( Figure 6C ; Figures S5A-S5D ). This confirms the suitability of PSTs for optically defined MT depolymerization in mammalian tissue in vivo.
DISCUSSION
Biological implementations of photoswitchable small molecules have traditionally focused on transmembrane proteins, usually expressed in neurons, whose inherently nonlinear response has contributed to many successful applications (Fehrentz et al., 2011) . Here, we show that photopharmacology also offers valuable applications to intracellular targets such as the microtubule cytoskeleton, which is highly conserved and fundamental to all eukaryotes (Dumontet and Jordan, 2010) . The PSTs embed a photoswitch inside the CDI pharmacophore, generating minimal-complexity cell permeant compounds which are straightforward to synthesize and can be applied as watersoluble prodrugs. The PSTs have reproduced the MT disrupting, cytostatic, and cytotoxic effects of their CDI isosteres (Bhattacharyya et al., 2008) through in vitro, in cellulo, and in vivo assays, with the novel advantage that PSTs can spatially and temporally target these effects with full reversibility.
PSTs can exploit visible light trans4cis photoswitching, combined with spontaneous cis/trans relaxation, to create steep cis/trans spatiotemporal gradients even in vivo. Since the cis-PSTs are two orders of magnitude more potent than the trans-PSTs, this allows them to apply their strong bioactivity in a highly localized fashion. The PSTs' temporal specificity on the order of seconds, and spatial specificity down to at least the single-cell level, enable a variety of precise and fully reversible studies which are inaccessible to the current MT inhibitors. We envision that finely localized light delivery, possibly combined with substitution patterns that give faster spontaneous , and total distance traveled (E) show that PST-1 treatment allows for full, reversible optical control over microtubule dynamics in cellulo, with MT dynamics being blocked under phases of blue illumination but resuming normal behavior under phases of green illumination. Grey bars represent data for cells illuminated but without PST-1 treatment, while colored bars represent cells illuminated and treated with PST-1 at 10 mM (for which the color indicates the phase's illumination wavelength). Data were assembled from u-track analysis of multiple independent movies acquired as in (A), and are given as mean ± SEM for each phase, with phases arranged in chronological order; each phase lasted 2 min. The bleaching of the mCherry tag over the course of the experiment reduces the automatic detection of EB3 comets by u-track, which progressively reduces the apparent comet number determined by conservative analysis (B); for unbiased analysis consult the original data in Movies S1 and S2.
cis/trans relaxation, may also allow PSTs to achieve subcellularly localized MT inhibition. The reversibility of the PSTs' bioactivity allows quick recovery of normal MT function after PST treatment, so studies may establish not only the short-term consequences of inhibiting MT-dependent processes, but also their long-term effects on the whole organism. We therefore expect that PSTs will prove useful tools for spatiotemporally precise research into a range of MT-dependent processes, including intracellular transport, synaptic plasticity, cell division, motility, invasion, and angiogenesis, revealing new insights in cellular and developmental biology as well as in vivo physiology. Considering medical applications, we anticipate that the cisPSTs will share many of the features that especially suit CA4 to tumor chemotherapy (Tron et al., 2006) , in addition to the cytotoxic and antimitotic properties we have demonstrated. Crucially, however, the PSTs may avoid the therapeutically limiting side effects of the current MT inhibitors, as PSTs applied globally may be activated locally by precise illumination in vivo. This will benefit from the light delivery methods developed over decades of research in photodynamic therapy, and more recently, in optogenetics (Grossweiner, 2005; Ibsen et al., 2013) . It may be possible to use dual wavelength illuminations to actively restrain the cis form inside a protective ''belt zone'' ( Figure S1F ). We also anticipate that the PSTs' spontaneous cis/trans relaxation, on the scale of minutes, can passively reduce systemic exposure to bioactive cis-PSTs. PSTs may thus be used to deliver stronger on-target effects than can be achieved with the current, globally active MT inhibitors, while simultaneously reducing the accompanying side effects. Therefore we envision that PSTs will not only prove to be useful tools for cell biology, but also promise to deliver more efficient cancer chemotherapy, using the spatiotemporal precision of photopharmacology.
EXPERIMENTAL PROCEDURES Chemical Synthesis and Photocharacterizations
PSTs were synthesized and characterized by standard chemical methods. The UV-visible absorption spectra of the cis and trans isomers were determined by HPLC-UV-Vis. A monochromator was used to perform trans4cis isomerizations in vitro, with readout by UV-Vis spectroscopy. UV-Vis spectroscopy was used to monitor spontaneous cis/trans relaxation. Full design, synthesis, and photocharacterization of the PSTs is detailed in the Supplemental Information.
Cell Culture Assays MDA-MB-231, Jurkat, HEK293T, and HeLa cell lines were maintained under standard cell culture conditions. PSTs were applied using a minimum of cosolvent, typically 2% acetonitrile for 100 mM PST. Cells were incubated in lightproof boxes, either in the dark (trans-PSTs) or with pulsed illuminations using a home-made ''Disco'' LED lighting system (cis-PSTs and rescue protocol). The Disco uses an Arduino microcomputer to operate arrays of LEDs that can be placed under or over well plates to illuminate them during an experiment. Typically, 10-30 well plates per assay were illuminated using independent pulse timings and wavelengths ( Figure S6 ). Crystal violet staining (Saotome et al., 1989) and MTT assay (Cushman et al., 1991) were performed according to standard protocols. Nuclear fragmentation, cell-cycle analysis and propidium iodide exclusion assays were performed using flow cytometry analysis according to standard procedures (Nicoletti et al., 1991) . Full details of cell culture assays and a guide to build and run the Disco LED system are given in the Supplemental Information.
In Vitro Tubulin Radioligand Binding Competition Assay Scintillation proximity assay was performed as described (Tahir et al., 2000) , with the Disco LED system used to apply 390 nm light pulses to assay cis-PST-1 (see Supplemental Information for further details). (A and B) PSTs achieve fully reversible optical control over mitosis within a living organism, with single-cell spatial precision (see full data in Movies S4 and S5). C. elegans embryos expressing mCherry::H2B and mCherry::PH were bathed in 40 mM PST-1, and a single cell in each embryo was illuminated at either 405 nm (blue ROI, toxic regime) or 405 + 514 nm (green ROI, rescue protocol). Cells illuminated by the toxic regime showed mitotic arrest (stationary chromosomes marked with red arrows), while in cells exposed to the rescue protocol, chromosomes continued to segregate (yellow arrows); neighboring cells continued mitosis unperturbed. Scale bars, 10 mm; time is shown relative to chromosome organization into the metaphase plate (start of illumination); two z-slices are given in (B) at t = 8 min, as the cells of interest had moved to distinct focal planes; see also Figures S4B-S4G. (C) PST-1P applied in living mouse tissue gives complete MT disruption under 390 nm light, but has no effects in the dark. The cremaster muscle in live C57BL/6 mice was superfused with 50 mM PST-1P or with PBS (''ctrl'') for 40 min while dark conditions or 390 nm were applied. Muscle was then excised, fixed, and stained for a-tubulin (yellow) and nuclei (red). 3D-rendered z-stacks of total thickness 30 mm are shown; scale bars, 15 mm. See also Figure S5 .
In Vitro Tubulin Polymerization Assay Tubulin polymerization assay was performed as described (Lin et al., 1988) , with a monochromator used to apply 390 nm light to assay the cis-PSTs (see Supplemental Information for further details).
Fixed and Live Cell Imaging by Confocal Microscopy
For fixed cell imaging, MDA-MB-231 cells were incubated with PST under illumination by the Disco system, then washed with extraction buffer to remove monomeric and dimeric tubulin subunits, fixed with glutaraldehyde, and immunostained for a-tubulin by standard methods, then imaged with a Zeiss LSM 510 Meta confocal microscope. For video microscopy, HeLa cells were transiently transfected with EB3-mCherry plasmid using the jetPRIME reagent. Following the addition of PST-1, EB3-mCherry was imaged at 561 nm at a rate of 17 frames per minute using an UltraVIEW VOX spinning-disk confocal microscope, while cells were exposed to alternating phases of pulsed photoisomerization illuminations (one 100 ms pulse every 3.53 s) using lasers at 405 nm and 514 nm, with each phase lasting for 2 min (see Supplemental Information for further details). EB3 comets were tracked and analyzed with the MATLAB software u-track (Applegate et al., 2011) ; data for corresponding photoisomerization phases were averaged across multiple independent experiments to yield the final statistics.
C. elegans Video Microscopy
The C. elegans fluorescent strain ANA090 was cultured using standard protocols and maintained at 25 C. RNAi against perm-1 was performed by feeding ANA090 L4 larva on HT115 bacteria for 24 hr according to standard protocol (Carvalho et al., 2011) , then embryos were mounted with 40 mM PST-1 and imaged at 561 nm using a Zeiss LSM 710 confocal microscope, using 405 nm and 514 nm laser ROI illuminations to achieve PST photoisomerizations within selected cells (see Supplemental Information for further details).
Mouse Cremaster Muscle Experiment
Male C57BL/6 mice at the age of 10-12 weeks were prepared for microsurgery of the cremaster muscle as previously described (Baez, 1973) , and 50 mM PST-1P was added to the superfusion solution. For 40 min, animals were either kept in the dark, or else had the pelvic region illuminated by a 390 nm LED with milliwatt-range light output. Animals were then sacrificed, and the tissue was excised, immunostained, and imaged on a Leica SP5 confocal microscope following standard procedures (Rehberg et al., 2010) 
